SRSF1 and breast cancer: CLK2 knockdown significantly reduced the phosphorylation level of the splicing factor SRSF1, promoted ENAH 11a inclusion, generated ENAH-L isoforms, and facilitated EMT in breast cancer (Fig. 4C).